Health Catalyst Inc expected to post earnings of 3 cents a share - Earnings Preview

Health Catalyst

05/08/2025 23:25

Health Catalyst Inc HCAT.OQ HCAT.O is expected to  show a rise in quarterly revenue when it reports  results on August 7 for the period ending June 30 2025

The South Jordan Utah-based  company is expected to report a 6.2% increase in revenue to $80.608 million from $75.9 million a year ago, according to the mean estimate from 12 analysts, based on LSEG data.The company's guidance on May 7 2025, for the period ended June 30, was for revenue of $80.500 million.

​LSEG's mean analyst estimate for Health Catalyst Inc is for earnings of 3 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Health Catalyst Inc is $6.50, about 41.2% above its last closing price of $3.82

The company's guidance on May 7 2025 for the period ended June 30 was for Earnings before Interest, Taxes, Depreciation and Amortization of of USD8 million.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
0.00
0.00
0.01
Beat
400
Dec. 31 2025
0.07
0.07
0.04
Missed
-45.9
Sep. 30 2024
0.10
0.10
0.07
Missed
-28.3​
Jun. 30 2024
0.09
0.08
0.12
Beat
51.3
​​Mar. 31 2024
0.03
0.03
0.05
Beat
79
Dec. 31 2023
0.01
0.00
0.02
Beat
2,700​
Sep. 30 2023
0.00
-0.02
0.03
Beat
275.6
Jun. 30 2023
-0.01
0.00
0.05
Beat
1,447.7

This summary was machine generated August 5 at 22:25 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)